We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt
Jan 04
Spanish (IBEX) Healthcare Sector Analysis
UpdatedJan 27, 2023
DataAggregated Company Financials
Companies16
- 7D2.6%
- 3M16.5%
- 1Y-21.1%
- YTD5.6%
In the last week, the Healthcare industry is up 2.6%, with Grifols up 4.1%. In contrast, the industry has lost 21% in the last 12 months. Earnings are forecast to grow by 25% annually.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 27 Jan 2023 | €14.7b | €8.4b | €430.6m | 13.8x | 34.2x | 1.8x |
| Sun, 25 Dec 2022 | €13.8b | €8.4b | €430.5m | 14.1x | 32x | 1.6x |
| Tue, 22 Nov 2022 | €13.6b | €8.4b | €440.1m | 14.5x | 30.8x | 1.6x |
| Thu, 20 Oct 2022 | €12.6b | €8.4b | €462.3m | 13.4x | 27.2x | 1.5x |
| Sat, 17 Sep 2022 | €14.9b | €8.3b | €465.4m | 13.4x | 32x | 1.8x |
| Mon, 15 Aug 2022 | €16.4b | €8.3b | €465.4m | 14.3x | 35.2x | 2x |
| Wed, 13 Jul 2022 | €19.0b | €7.9b | €514.1m | 14.5x | 37x | 2.4x |
| Fri, 10 Jun 2022 | €20.2b | €7.9b | €513.9m | 14.5x | 39.3x | 2.5x |
| Sun, 08 May 2022 | €20.4b | €7.8b | €485.6m | 14.3x | 42.1x | 2.6x |
| Tue, 05 Apr 2022 | €20.1b | €7.8b | €506.8m | 15.1x | 39.6x | 2.6x |
| Thu, 03 Mar 2022 | €20.1b | €7.7b | €475.4m | 18.1x | 42.3x | 2.6x |
| Sat, 29 Jan 2022 | €18.5b | €7.9b | €932.4m | 16.2x | 19.8x | 2.3x |
| Mon, 27 Dec 2021 | €19.0b | €7.9b | €931.9m | 16.6x | 20.4x | 2.4x |
| Wed, 24 Nov 2021 | €19.2b | €7.8b | €911.8m | 17.7x | 21.1x | 2.5x |
| Fri, 22 Oct 2021 | €21.6b | €7.8b | €912.6m | 19.5x | 23.7x | 2.8x |
| Sun, 19 Sep 2021 | €22.8b | €7.8b | €912.6m | 21.2x | 25x | 2.9x |
| Tue, 17 Aug 2021 | €22.3b | €7.8b | €912.6m | 18.5x | 24.5x | 2.9x |
| Tue, 01 Jun 2021 | €23.2b | €7.7b | €876.2m | 21.7x | 26.5x | 3x |
| Fri, 05 Mar 2021 | €21.5b | €7.8b | €977.0m | 23.1x | 22x | 2.7x |
| Mon, 07 Dec 2020 | €22.3b | €7.9b | €1.0b | 15.5x | 21.2x | 2.8x |
| Thu, 10 Sep 2020 | €19.9b | €7.8b | €910.8m | 16.8x | 21.9x | 2.6x |
| Wed, 03 Jun 2020 | €23.1b | €7.7b | €1.0b | 17x | 22.4x | 3x |
| Sat, 07 Mar 2020 | €23.1b | €7.3b | €854.5m | 19.3x | 27x | 3.2x |
Price to Earnings Ratio
28.5x
Current Industry PE
- Investors are optimistic on the Spanish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 34.2x which is higher than its 3-year average PE of 26.8x.
- The 3-year average PS ratio of 2.6x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 20% per year over the last three years.
- Meanwhile revenues for these companies have grown 4.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 2.49% | |
| Healthcare | 2.57% | |
| Biotech | 3.18% | |
| Life Sciences | 2.48% | |
| Pharma | 2.17% | |
| Healthtech | 0% | |
| Healthcare Services | -0.19% | |
| Medical Equipment | -2.51% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 75.0x.
- Analysts are expecting annual earnings growth of 54.3%, which is higher than its past year's earnings growth of 5.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 81% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GRF Grifols | €12.56 | 4.1% +€339.5m | -20.1% | PE143x | |
| ROVI Laboratorios Farmaceuticos Rovi | €38.50 | 5.1% +€100.3m | -39.8% | PE11.7x | |
| ALM Almirall | €9.23 | 0.9% +€14.5m | -18.8% | PE177.5x | |
| CBAV Clínica Baviera | €18.70 | 3.9% +€11.4m | -11.8% | PE10.3x | |
| RJF Laboratorio Reig Jofre | €2.52 | 3.7% +€7.0m | -15.4% | PE46x |
